At ASCO 2018, Oncology Practice Management
) discussed the current state of genetics and genomic testing, the increasing understanding of biomarkers, and how they influence the treatment of patients with lung cancer. The discussion highlighted the interaction between oncologists and pathologists to facilitate best outcomes for patients. This interview included Lauren Ritterhouse, MD, PhD, Co-Director, Clinical Genomics Lab, University of Chicago, IL, and Geoff Oxnard, MD, Thoracic Oncologist, Dana-Farber Cancer Institute, and Associate Professor of Medicine, Harvard Medical School, Boston, MA.
[ Read More ]